{"entity":{"type":"insider","cik":"0001267093","url":"/insider/0001267093","json_url":"/insider/0001267093.json","name":"AVENTIS PHARMACEUTICALS INC","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":7,"n_filings":5,"first":"2003-11-05","last":"2004-01-16","span_basis":"filed_date"},"name_variants":[{"name":"AVENTIS PHARMACEUTICALS INC","source":"filing","n_filings":5,"first_seen":"2003-11-05","last_seen":"2004-01-16"}],"transactions":[{"id":547668,"accession":"0001267093-04-000003","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001267093-04-000003","line_url":"/filing/0001267093-04-000003#line-1","is_derivative":false,"issuer_cik":"0000217028","issuer_name":"VIROPHARMA INC","issuer_ticker":"VPHM","issuer_name_source":null,"issuer_url":"/issuer/0000217028","owner_cik":null,"owner_name":"AVENTIS INC; AVENTIS PHARMACEUTICALS INC; AVENTIS HOLDINGS INC","owner_display_name":"AVENTIS INC","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22100.0,"shares_display":"22,100","price_per_share":3.51,"price_display":"3.51","price_state":"stated","total_value":77571.0,"total_display":"77,571.00","total_whole":"77,571","shares_owned_after":2616000.0,"shares_owned_after_display":"2,616,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2004-01-14","filed_date":"2004-01-16","scope":"insider"},{"id":588213,"accession":"0001267093-04-000002","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001267093-04-000002","line_url":"/filing/0001267093-04-000002#line-2","is_derivative":false,"issuer_cik":"0000217028","issuer_name":"VIROPHARMA INC","issuer_ticker":"VPHM","issuer_name_source":null,"issuer_url":"/issuer/0000217028","owner_cik":null,"owner_name":"AVENTIS INC; AVENTIS HOLDINGS INC; AVENTIS PHARMACEUTICALS INC","owner_display_name":"AVENTIS INC","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":31000.0,"shares_display":"31,000","price_per_share":3.49,"price_display":"3.49","price_state":"stated","total_value":108190.0,"total_display":"108,190.00","total_whole":"108,190","shares_owned_after":2638100.0,"shares_owned_after_display":"2,638,100","ownership_form":"D","is_10b5_1":null,"transaction_date":"2004-01-13","filed_date":"2004-01-14","scope":"insider"},{"id":588212,"accession":"0001267093-04-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001267093-04-000002","line_url":"/filing/0001267093-04-000002#line-1","is_derivative":false,"issuer_cik":"0000217028","issuer_name":"VIROPHARMA INC","issuer_ticker":"VPHM","issuer_name_source":null,"issuer_url":"/issuer/0000217028","owner_cik":null,"owner_name":"AVENTIS INC; AVENTIS HOLDINGS INC; AVENTIS PHARMACEUTICALS INC","owner_display_name":"AVENTIS INC","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":95900.0,"shares_display":"95,900","price_per_share":3.36,"price_display":"3.36","price_state":"stated","total_value":322224.0,"total_display":"322,224.00","total_whole":"322,224","shares_owned_after":2669100.0,"shares_owned_after_display":"2,669,100","ownership_form":"D","is_10b5_1":null,"transaction_date":"2004-01-12","filed_date":"2004-01-14","scope":"insider"},{"id":466253,"accession":"0001267093-04-000001","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001267093-04-000001","line_url":"/filing/0001267093-04-000001#line-1","is_derivative":false,"issuer_cik":"0000217028","issuer_name":"VIROPHARMA INC","issuer_ticker":"VPHM","issuer_name_source":null,"issuer_url":"/issuer/0000217028","owner_cik":null,"owner_name":"AVENTIS HOLDINGS INC; AVENTIS INC; AVENTIS PHARMACEUTICALS INC","owner_display_name":"AVENTIS HOLDINGS INC","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":59000.0,"shares_display":"59,000","price_per_share":3.18,"price_display":"3.18","price_state":"stated","total_value":187620.0,"total_display":"187,620.00","total_whole":"187,620","shares_owned_after":2765000.0,"shares_owned_after_display":"2,765,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2004-01-09","filed_date":"2004-01-12","scope":"insider"},{"id":92947,"accession":"0001267093-03-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001267093-03-000002","line_url":"/filing/0001267093-03-000002#line-1","is_derivative":false,"issuer_cik":"0000217028","issuer_name":"VIROPHARMA INC","issuer_ticker":"VPHM","issuer_name_source":null,"issuer_url":"/issuer/0000217028","owner_cik":null,"owner_name":"AVENTIS HOLDINGS INC; AVENTIS INC; AVENTIS PHARMACEUTICALS INC","owner_display_name":"AVENTIS HOLDINGS INC","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15012.0,"shares_display":"15,012","price_per_share":3.15,"price_display":"3.15","price_state":"stated","total_value":47287.8,"total_display":"47,287.80","total_whole":"47,288","shares_owned_after":2824000.0,"shares_owned_after_display":"2,824,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2003-11-25","filed_date":"2003-11-26","scope":"insider"},{"id":21342,"accession":"0001267093-03-000001","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001267093-03-000001","line_url":"/filing/0001267093-03-000001#line-2","is_derivative":false,"issuer_cik":"0000217028","issuer_name":"VIROPHARMA INC","issuer_ticker":"VPHM","issuer_name_source":null,"issuer_url":"/issuer/0000217028","owner_cik":null,"owner_name":"AVENTIS PHARMACEUTICALS INC; AVENITS HOLDINGS INC; AVENTIS INC","owner_display_name":"AVENTIS PHARMACEUTICALS INC","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25988.0,"shares_display":"25,988","price_per_share":3.3,"price_display":"3.30","price_state":"stated","total_value":85760.4,"total_display":"85,760.40","total_whole":"85,760","shares_owned_after":2839012.0,"shares_owned_after_display":"2,839,012","ownership_form":"D","is_10b5_1":null,"transaction_date":"2003-11-04","filed_date":"2003-11-05","scope":"insider"},{"id":21341,"accession":"0001267093-03-000001","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001267093-03-000001","line_url":"/filing/0001267093-03-000001#line-1","is_derivative":false,"issuer_cik":"0000217028","issuer_name":"VIROPHARMA INC","issuer_ticker":"VPHM","issuer_name_source":null,"issuer_url":"/issuer/0000217028","owner_cik":null,"owner_name":"AVENTIS PHARMACEUTICALS INC; AVENITS HOLDINGS INC; AVENTIS INC","owner_display_name":"AVENTIS PHARMACEUTICALS INC","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":135000.0,"shares_display":"135,000","price_per_share":3.17,"price_display":"3.17","price_state":"stated","total_value":427950.0,"total_display":"427,950.00","total_whole":"427,950","shares_owned_after":2865000.0,"shares_owned_after_display":"2,865,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2003-11-03","filed_date":"2003-11-05","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000946840","name":"VIROPHARMA INC","url":"/issuer/0000946840","role":"Ten percent owner, Other","n_filings":5,"first_seen":"2003-11-05","last_seen":"2004-01-16"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001267093","retrieved_at":"2026-08-27T09:15:58+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}